Drug Profile
ONO 9330547
Alternative Names: ONO-9330547Latest Information Update: 27 Sep 2023
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class Small molecules
- Mechanism of Action Axl receptor tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute myeloid leukaemia
Most Recent Events
- 27 Sep 2023 Discontinued - Preclinical for Acute myeloid leukaemia in Japan (PO)
- 28 Jan 2021 No recent reports of development identified for preclinical development in Acute-myeloid-leukaemia in Japan (PO)
- 23 Jan 2017 Pharmacodynamics data from a preclinical study in Acute myeloid leukemia released by Ono Pharmaceuticals before January 2017